AAAAAA
Results:
1-16
|
Results: 16
Authors:
KOZA V
JINDRA P
SVOJGROVA M
CETKOVSKY P
Citation: V. Koza et al., SUCCESSFUL AUTOLOGOUS TRANSPLANTATION IN A PATIENT WITH SEVERE APLASTIC-ANEMIA (SAA), Bone marrow transplantation, 21(9), 1998, pp. 957-959
Authors:
CETKOVSKY P
KOZA V
CETKOVSKA P
SVOJGROVA M
Citation: P. Cetkovsky et al., SUCCESSFUL TREATMENT OF SEVERE SHULMANS-SYNDROME BY ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21(6), 1998, pp. 637-639
Authors:
KOZA V
JINDRA P
CETKOVSKY P
Citation: V. Koza et al., PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN THE PERIOD OF HEMATOPOIESIS RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 70-70
Authors:
CETKOVSKY P
KOZA V
CETKOVSKA P
PIZINGER K
SVOJGROVA M
Citation: P. Cetkovsky et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF SEVERE SHULMANS-SYNDROME, Bone marrow transplantation, 21, 1998, pp. 188-188
Authors:
JINDRA P
KOZA V
Citation: P. Jindra et V. Koza, FLUDARABINE FOLLOWED BY HDC WITH CD-34- IN CLL WITH IMMUNE COMPLICATIONS - A CASE-STUDY( SELECTED PBSC COULD BE USEFUL ), Bone marrow transplantation, 21, 1998, pp. 276-276
Authors:
CETKOVSKY P
KOZA V
JINDRA P
SKOPEK P
SVOJGROVA M
Citation: P. Cetkovsky et al., FLUOROQUINOLONE PLUS TRIMETHOPRIM SULFAMETHOXAZOLE (TMS) VERSUS FLUOROQUINOLONE (FQ) ALONE FOR ANTIBACTERIAL PROPHYLAXIS IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS/, Bone marrow transplantation, 21, 1998, pp. 538-538
Authors:
ADAM Z
HAJEK R
SCUDLA Z
KUCA B
KOZA V
DRBAL J
INDRAK K
CAHOVA S
GUMULEC J
JANUSKA J
LEHANKA F
PRASKAC P
REZEK Z
VEPREK L
KREJCI M
BACOVSKY J
FRANKOVA H
SVOJGROVA M
PAPAJIK T
MARESCHOVA I
MAYER J
VORLICEK J
Citation: Z. Adam et al., THERAPY OF MULTIPLE-MYELOMA WITH HIGH-DOSE MELPHALAN AND PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT - FOLLOWED MAINTENANCE THERAPY WITH INTERFERON-ALPHA-2B (IFN) MONOTHERAPY OR SEQUENTIAL MAINTENANCE THERAPY IFN AND DEXAMETHASONE (DEX) - REPORT FROM ONGOING TRIAL 4W OF CZECH MYELOMA GROUP, Bone marrow transplantation, 21, 1998, pp. 740-740
Authors:
CARRERAS E
BERTZ H
ARCESE W
VERNANT JP
TOMAS JF
HAGGLUND H
BANDINI G
ESPEROU H
RUSSELL J
DELARUBIA J
DIGIROLAMO G
DEMUYNCK H
HARTMANN O
CLAUSEN J
RUUTU T
LEBLOND V
IRIONDO A
BOSI A
BENBASSAT I
KOZA V
GRATWOHL A
APPERLEY JF
Citation: E. Carreras et al., INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 92(10), 1998, pp. 3599-3604
Authors:
CLEAVER SA
WARREN P
KERN M
HURLEY CK
RAFFOUX C
KELLER J
KIESEL U
KOZA V
MARRY E
MITTERSCHIFFTHALER A
NAKAMURA M
OKAH CT
PERSSON U
RADDESTEPANIAK T
RANSON L
RAYMOND J
DOROSARIOSANCHO M
VARLALEFTHERIOTI M
WIEGAND T
WINTERHAGER JM
WOODFIELD DG
Citation: Sa. Cleaver et al., DONOR WORK-UP AND TRANSPORT OF BONE-MARROW - RECOMMENDATIONS AND REQUIREMENTS FOR A STANDARDIZED PRACTICE THROUGHOUT THE WORLD FROM THE DONOR REGISTRIES AND QUALITY ASSURANCE WORKING GROUPS OF THE WORLD-MARROW-DONOR-ASSOCIATION (VVMDA), Bone marrow transplantation, 20(8), 1997, pp. 621-629
Authors:
CETKOVSKY P
KOZA V
JINDRA P
SKOPEK P
SVOJGROVA M
Citation: P. Cetkovsky et al., INDIVIDUAL CRITERIA COULD BE OPTIMAL FOR STARTING G-CSF APPLICATION AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 20(8), 1997, pp. 639-641
Authors:
JINDRA P
KOZA V
CETKOVSKY P
VOZOBULOVA V
SCHUTZOVA M
Citation: P. Jindra et al., CYCLOPHOSPHAMIDE-3 G M(2) AND G-CSF IS AN EFFECTIVE AND SAFE OUTPATIENT-BASED PBSC MOBILIZING REGIMEN - A SINGLE-CENTER EXPERIENCE/, Bone marrow transplantation, 20(1), 1997, pp. 91-93
Authors:
CARRERAS E
BERTZ H
VERNANT JP
TOMAS JF
HAGGLUND H
BANDINI G
ESPEROU H
RUSELL J
DELARUBIA J
DIGIROLAMO G
CLEEREN M
HARTMANN O
RUUTU T
LEBLOND V
IRIONDO A
BOSI A
BENBASSAT I
KOZA V
GRATWOHL A
APPERLEY J
Citation: E. Carreras et al., INCIDENCE OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) AFTER BMT IN EUROPE - A PROSPECTIVE COHORT STUDY OF THE EBMT, Blood, 88(10), 1996, pp. 1647-1647
Authors:
CETKOVSKY P
KOZA V
CEPELAK V
VIT L
Citation: P. Cetkovsky et al., HEMOSTASIS IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH INTERMEDIATE-DOSE OF CYTOSINE-ARABINOSIDE AND MITOXANTRONE - THE INFLUENCE OF CHEMOTHERAPY, INFECTION AND REMISSION STATUS ON HEMOSTASIS, Fibrinolysis, 9(3), 1995, pp. 165-169
Authors:
CETKOVSKY P
KOZA V
Citation: P. Cetkovsky et V. Koza, SALIVARY-GLANDS ENLARGEMENT IN ASSOCIATION WITH CYTOSINE-ARABINOSIDE APPLICATION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, European journal of cancer, 30A(11), 1994, pp. 1727-1728
Authors:
CETKOVSKY P
KOZA V
CEPELAK V
VIT L
Citation: P. Cetkovsky et al., THE INFLUENCE OF INDUCTION CHEMOTHERAPY AND REMISSION STATUS ON HEMOSTASIS IN PATIENTS TREATED FOR ACUTE MYELOID-LEUKEMIA, Blood coagulation & fibrinolysis, 5(3), 1994, pp. 349-353
Authors:
CETKOVSKY P
KOZA V
CEPELAK V
VIT L
SIGUTOVA P
Citation: P. Cetkovsky et al., HEMOSTATIC CHANGES IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA DURING AND AFTER REMISSION INDUCTION THERAPY, Fibrinolysis, 7(6), 1993, pp. 386-390
Risultati:
1-16
|